Amgen 
Welcome,         Profile    Billing    Logout  
 160 Products   813 Diseases   160 Products   1608 Trials   78055 News 


«12...880881882883884885886887888889890...903904»
  • ||||||||||  Ravicti (glycerol phenylbutyrate) / Immedica, Amgen
    New P2 trial:  Use of Ravicti (clinicaltrials.gov) -  Jun 18, 2013   
    P2,  N=6, Recruiting, 
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Trial completion:  CAMEO: Canadian Methotrexate and Etanercept Outcome Study (clinicaltrials.gov) -  Jun 17, 2013   
    P=N/A,  N=257, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
    Trial termination:  MT2004-30: Tomotherapy for Solid Tumors (clinicaltrials.gov) -  Jun 10, 2013   
    P1,  N=23, Terminated, 
    N=99 --> 147 Active, not recruiting --> Terminated; Replaced by another study
  • ||||||||||  Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
    Enrollment change:  MT2004-30: Tomotherapy for Solid Tumors (clinicaltrials.gov) -  Jun 10, 2013   
    P1,  N=23, Terminated, 
    Active, not recruiting --> Terminated; Replaced by another study N=45 --> 23
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Enrollment open:  Islet After Kidney Transplant for Type 1 Diabetes (clinicaltrials.gov) -  Jun 6, 2013   
    P1/2,  N=10, Recruiting, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
  • ||||||||||  humanised dinutuximab (Hu14.18K322A) / Essential Pharma
    Enrollment change:  Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) -  Jun 3, 2013   
    P2,  N=42, Recruiting, 
    Recruiting --> Active, not recruiting N=110 --> 42
  • ||||||||||  humanised dinutuximab (Hu14.18K322A) / Essential Pharma
    Enrollment open:  Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) -  Jun 3, 2013   
    P2,  N=42, Recruiting, 
    N=110 --> 42 Not yet recruiting --> Recruiting